Profitability
Weight: 15%
F
0
- 5yr Avg ROIC -43.4%
KURA
Kura Oncology, Inc.
AlphaQuality composite grade, weighted for high-growth software businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.
Grade overrides the 20.9 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -59.7%
- 5yr Share-Count CAGR 10.6%
Growth Quality
Weight: 35%
F
20
- Revenue-Growth Years (5) 1/5
Cash Generation
Weight: 20%
C
55
- 5yr FCF Margin 71.8%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 10%
F
0
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) -183.11x
- Altman Z-Score -1.33
Stability
Weight: 5%
C+
58
- Negative-Revenue Years (5) 0/5
- Piotroski F-Score 2
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.1 of 1 gurus held; 1 new buy.
- Holders
- 1
- Avg Δ position
- —
- New buys
- 1
- Full exits
- 0
- Cooperman new